<?xml-model href='http://www.tei-c.org/release/xml/tei/custom/schema/relaxng/tei_all.rng' schematypens='http://relaxng.org/ns/structure/1.0'?><TEI xmlns="http://www.tei-c.org/ns/1.0">
	<teiHeader>
		<fileDesc>
			<titleStmt><title level='a'>Bioinspired synthesis and characterization of zinc oxide nanoparticles and assessment of their cytotoxicity and antimicrobial efficacy</title></titleStmt>
			<publicationStmt>
				<publisher>Discover Applied Sciences</publisher>
				<date>03/01/2024</date>
			</publicationStmt>
			<sourceDesc>
				<bibl> 
					<idno type="par_id">10511113</idno>
					<idno type="doi">10.1007/s42452-024-05719-2</idno>
					<title level='j'>Discover Applied Sciences</title>
<idno>3004-9261</idno>
<biblScope unit="volume">6</biblScope>
<biblScope unit="issue">3</biblScope>					

					<author>Rajeev Acharya</author><author>Felix Tettey</author><author>Aakash Gupta</author><author>Khaga Raj Sharma</author><author>Niranjan Parajuli</author><author>Narayan Bhattarai</author>
				</bibl>
			</sourceDesc>
		</fileDesc>
		<profileDesc>
			<abstract><ab><![CDATA[<title>Abstract</title> <p>Zinc oxide nanoparticles (ZnO NPs) are versatile and promising, with diverse applications in environmental remediation, nanomedicine, cancer treatment, and drug delivery. In this study, ZnO NPs were synthesized utilizing extracts derived from<italic>Acacia catechu, Artemisia vulgaris</italic>, and<italic>Cynodon dactylon</italic>. The synthesized ZnO NPs showed an Ultraviolet–visible spectrum at 370nm, and X-ray diffraction analysis indicated the hexagonal wurtzite framework with the average crystallite size of 15.07nm, 16.98nm, and 18.97nm for nanoparticles synthesized utilizing<italic>A. catechu, A. vulgaris,</italic>and<italic>C. dactylon</italic>respectively. Scanning electron microscopy (SEM) demonstrated spherical surface morphology with average diameters of 18.5nm, 17.82nm, and 17.83nm for ZnO NPs prepared from<italic>A. catechu, A. vulgaris</italic>, and<italic>C. dactylon,</italic>respectively. Furthermore, ZnO NPs tested against<italic>Staphylococcus aureus, Kocuria rhizophila, Klebsiella pneumonia,</italic>and<italic>Shigella sonnei</italic>demonstrated a zone of inhibition of 8 to 14mm. The cell viability and cytotoxicity effects of ZnO NPs were studied on NIH-3T3 mouse fibroblast cells treated with different concentrations (5μg/mL, 10μg/mL, and 50μg/mL). The results showed biocompatibility of all samples, except with higher doses causing cell death. In conclusion, the ZnO NPs synthesized through plant-mediated technique showed promise for potential utilization in various biomedical applications in the future.</p>]]></ab></abstract>
		</profileDesc>
	</teiHeader>
	<text><body xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink">
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="1">Introduction</head><p>Nanotechnology is one of the most active areas of research in modern material science which provides the capability to manipulate the material properties through precise control of their size and morphology. It is gaining prominence across various sectors such as healthcare, beauty products, computers, optics, catalysis, food technology, biomedical applications, pharmaceutical companies, and environmental remediation <ref type="bibr">[1,</ref><ref type="bibr">2]</ref>. The tiny size and the remarkable surfaceto-volume ratio of nano-sized materials make them so interesting that they exhibit greater reactivity compared to bulk materials <ref type="bibr">[3]</ref>. Among a variety of metal oxide nanoparticles like TiO 2 , FeO, CuO, SiO 2, and NiO, ZnO is highly favored due to simplicity in synthesis, remarkable selectivity, biocompatibility, non-toxicity, enhanced optoelectronic properties <ref type="bibr">[4]</ref>, and significant band gap of approximately 3.37 eV, and an elevated exciton binding energy of 60 meV <ref type="bibr">[5]</ref>.</p><p>As per the safety data sheet provided by USFDA, ZnO falls under the categorization of a "Generally Recognized as Safe" (GRAS) material and demonstrates antibacterial, antifungal, antidiabetic, and anticancer properties <ref type="bibr">[6]</ref>. These properties are ascribed to their tiny dimensions that possess the capacity to enter and move through, allowing them to breach the biological barriers, disrupt cellular functions, and navigate through various biological systems of the host resulting in uncontrolled cell proliferation and death <ref type="bibr">[7]</ref>. The antimicrobial effect of ZnO NPs arises from either direct adherence to cell walls or indirectly generating reactive oxygen species (ROS) upon exposure to biological fluids or moisture that causes oxidative stress, disrupting microbial membranes, functions, enzymatic activity, and replication ultimately inhibiting microorganisms <ref type="bibr">[8,</ref><ref type="bibr">9]</ref>. The ROS mentioned above under physiological conditions, induces cellular damage and triggers apoptosis <ref type="bibr">[10]</ref>, and is responsible for anticancer activities. Additionally, ZnO NPs disrupt mitochondrial function <ref type="bibr">[11]</ref> and interfere with cell division and proliferation in cancerous cells. These properties supported by biocompatibility, non-toxicity, ease of fabrication, and remarkable selectivity <ref type="bibr">[12,</ref><ref type="bibr">13]</ref>, of ZnO NPs, collectively make them promising candidates for further exploration in anticancer studies <ref type="bibr">[13,</ref><ref type="bibr">14]</ref>. ZnO NPs have been produced through traditional physical and chemical approaches such as laser ablation <ref type="bibr">[15]</ref>, ball milling <ref type="bibr">[16]</ref>, sputtering <ref type="bibr">[17]</ref>, sol-gel technique <ref type="bibr">[18]</ref>, chemical vapor deposition <ref type="bibr">[19]</ref>, microemulsion <ref type="bibr">[20]</ref>, and hydrothermal methods <ref type="bibr">[21]</ref>. A more energy-efficient, beneficial, lesser complications, economical, and eco-friendly green approach has emerged, that entails the utilization of plant extracts, microorganisms, and biowaste materials and facilitates large-scale production at room temperature and overcomes the drawbacks of conventional techniques like the need for energetic processes, huge quantities of chemical substances, low output, cost and toxicity <ref type="bibr">[22]</ref><ref type="bibr">[23]</ref><ref type="bibr">[24]</ref>. Plant-mediated NP synthesis is carried out in three phases; reduction phase where metal ions from salt precursors undergo a reduction process from a higher oxidation state (O.S) to zero O.S which facilitates the nucleation of metal atoms, growth phase where the reduced metal aggregates and nucleates gradually to form NPs and stabilization phase where synthesized NPs are stabilized through a capping mechanism of plant metabolites <ref type="bibr">[25]</ref><ref type="bibr">[26]</ref><ref type="bibr">[27]</ref><ref type="bibr">[28]</ref>. Plant-based biomolecules like polyphenols, polysaccharides, alkaloids, vitamins, and flavonoids, function as both reducing and capping agents in NPs formation <ref type="bibr">[29]</ref><ref type="bibr">[30]</ref><ref type="bibr">[31]</ref>. The concentration of metal salt <ref type="bibr">[32]</ref>, type of plant extracts <ref type="bibr">[33]</ref>, solution pH <ref type="bibr">[33]</ref>, reaction time, and annealing temperature <ref type="bibr">[32]</ref>, significantly influence the shape, size, and overall quality of NPs synthesized through plant-mediated methods. Synthesis of ZnO NPs using orange peel extract <ref type="bibr">[34]</ref>, Artemisia pallens <ref type="bibr">[35]</ref>, Scoparia dulcis <ref type="bibr">[22]</ref>, Hibiscus sabdariffa <ref type="bibr">[36]</ref>, Bixa Orellana <ref type="bibr">[14]</ref>, Xanthomonas oryzae <ref type="bibr">[37]</ref>, Hagenia abyssinica <ref type="bibr">[4]</ref>, Pandanus odorifer <ref type="bibr">[38]</ref>, Cassia fistula <ref type="bibr">[39]</ref>, grape seed <ref type="bibr">[40]</ref>, Euphorbia abyssinica <ref type="bibr">[41]</ref>, and Cocos nucifera <ref type="bibr">[42]</ref>, had been previously studied for antimicrobial activities.</p><p>Similarly, in this work leaves of Acacia catechu, Artemisia vulgaris, and Cynodon dactylon were utilized for synthesizing ZnO NPs. A. catechu is a deciduous tree that is a member of the Fabaceae family and is native to South Asia, specifically in India, Nepal, and Myanmar. It is utilized for treating a variety of health issues and contains phytochemicals such as carbohydrates, proteins, thiols, tannins, phenolics, alkaloids, flavonoids, and glycosides <ref type="bibr">[43]</ref>. A. vulgaris is a perennial herb belonging to the Asteraceae family and is naturally occurring in Europe, Asia, and North Africa. It has been utilized in the management of digestive disorders, menstrual issues and as a tonic and contains phytochemicals, including flavonoids, essential oils, amino acids, carbohydrates, polyphenols, saponins, and tannins <ref type="bibr">[44]</ref>. C. dactylon is an evergreen turf that flourishes in warm climates of the Poaceae family, originating from Africa, Asia, and Australia. It has been traditionally employed in herbal medicine due to its therapeutic advantages <ref type="bibr">[45]</ref>. The phytochemicals of C. dactylon include flavonoids, alkaloids, steroids, terpenoids, triterpenoids, saponins, resins, tannins, fixed oils, and reducing sugars <ref type="bibr">[46]</ref>. The purpose of this study was to synthesize ZnO NPs utilizing locally available plants with therapeutic values namely A. catechu, A. vulgaris, and C. dactylon leaf extracts, and characterize the synthesized ZnO NPs through Ultraviolet-visible (UV-Vis),</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">Preparation of plant extracts</head><p>After collection, the plant parts were extensively rinsed with water and shade-dried for 2 weeks. The plant parts were ground finely with the help of an electric blender and then kept in air-tight plastic bags for further utilization <ref type="bibr">[1]</ref>. 1 g of fine powder of plants (A. catechu, A. vulgaris, C. dactylon) was blended with 50 mL of distilled water in a beaker. The mixture was stirred at 60 &#176;C followed by a water bath treatment at the same temperature for 1 h. The resultant suspension underwent filtration through Whatman No. 1 filter paper and was subsequently stored at 4 &#176;C for further use <ref type="bibr">[34]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">Synthesis of ZnO NPs</head><p>2 g of Zn(NO) 3 .6H 2 O was weighed and combined with 42.5 mL of respective plant extract in a beaker to prepare a 0.15 M suspension, followed by stirring for 1 h following the protocol suggested by Thi et al. <ref type="bibr">[34]</ref>. The mixture pH was maintained to 9 which is basic. Subsequently, the mixture was introduced into a water bath at 60 &#176;C for 1 h and subjected to hot air drying in an oven at 150 &#176;C, and the resulting residue was washed with ethanol 2-3 times followed by drying overnight in a desiccator. Finally, it was placed in the muffled furnace, maintained at 400 &#176;C for about 2 h, and powdered nanoparticles were obtained which were then stored in Eppendorf tubes for further characterization <ref type="bibr">[34]</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.4">Characterization of ZnO NPs</head><p>The ZnO NPs synthesized utilizing plant-mediated methods were subjected to morphological characterization through several techniques such as UV-visible spectroscopy, Fourier-transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), Scanning electron microscopy (SEM), and EDX. The confirmation of ZnO NPs synthesis was accomplished by analyzing the absorption band detected using a UV-visible spectrophotometer (SPECORD 200 PLUS, Analytik Jena, Germany) within 300-650 nm. Similarly, the stretching of the Zn-O bond and secondary metabolites present in the plant extracts was investigated through FTIR (IR Tracer 100-Shimadzu, Japan), analyzed in the spectral range within (4000-400) cm -1 . To determine the degree of crystallinity in the synthesized ZnO NPs, an X-ray diffraction pattern was acquired utilizing the (Rigaku D/MAX-2500/pc diffractometer, Germany) with monochromatic Cu K&#945; radiation of wavelength 1.5406 &#197;, 2&#952; scanned within the interval of 20-80&#176;. The size of the ZnO NPs crystallites was determined with Scherrer's equation <ref type="bibr">[47]</ref>, as follows:</p><p>Where D = Crystallite or grain size; K = dimensionless shape factor, with a value approximately close to unity (&#8776;0.9); &#955; = Wavelength of X-ray radiation employed, (0.15406 nm for CuK&#945;); &#952; = Bragg's angle (half of 2&#952; value of the selected peak; in radians); &#946; = Full-width half maximum (FWHM, in radians).</p><p>The surface composition and particle size of ZnO NPs were analyzed through SEM (JSM-7600/JEOL, Korea) coupled with EDX (JEM-2100F/JEOL, Korea) to find out the elemental composition of NPs functioned at a voltage of 10 kV.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.5">Antibacterial activity of ZnO NPs</head><p>The antibacterial effects of ZnO NPs derived from A. catechu, C. dactylon, and A. vulgaris were assessed through the disc diffusion method <ref type="bibr">[48]</ref>. The sterile cotton swab was used to spread a freshly prepared microbial culture of test organisms (Staphylococcus aureus (SA), Klebsiella pneumoniae (KP), Shigella sonnei (SS), and Kocuria rhizophila (KR)) onto an MHA plate. ZnO NPs (50 mg/mL), neomycin (1 mg/ mL, positive control), water (negative control), plant extract (20 mg/mL), blank A (20 mg/mL), and blank B (50 mg/mL) suspension/solution were loaded separately into sterile antimicrobial susceptibility discs and then put upon an MHA plate and incubated at 37 &#176;C for 18-24 h. Following the designated incubation period, the zone of inhibition (ZOI) was assessed along with the antimicrobial disc and noted in mm.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.6">Dose-response toxicity study of plant-mediated synthesized ZnO particles</head><p>All the ZnO NPs powder before exposure with the cells was UV-sterilized, suspended in ethanol for 15 min utilizing ultrasonication (Branson Ultrasonic Corporation, Danbury, CT, USA), and centrifuged (Z206-A Compact Centrifuge, Benchmark Scientific Inc, NJ, USA) at 4500 rpm for 10 min. The particles were then autoclaved and dispersed in a cell culture medium, DMEM supplemented with 10% serum. 1 mL of the particle suspension was treated with the cells. Before treatment with the cells, the NIH-3T3 cells, a mouse fibroblast cell line (ATTC 1658, Manassas, VA, USA) with a start density of 5 &#215; 10 4 was cultured in DMEM in a 48-well plate. After cells attained about 70% confluence, they were treated with different concentrations (i.e. 5 &#956;g/mL, 10 &#956;g/mL, and 50 &#956;g/mL of the ZnO NPs in a cell culture medium) and preserved in a humidified environment enriched with 5% CO 2 at 37 &#176;C for 72 h <ref type="bibr">[49]</ref><ref type="bibr">[50]</ref><ref type="bibr">[51]</ref>. The ZnO NPs samples from A. catechu were represented as AC-5, AC-10, and AC-50 whereas those from A. vulgaris were labeled as AV-5, AV-10, and AV-50. Additionally, those from C. dactylon were identified as CD-5, CD-10, and CD-50. Cells without treatment with the ZnO NPs were considered the control and labeled AC-0, AV-0, and CD-0. 100 &#181;L was obtained from the culture medium for all assays and all treatments were repeated three times.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.7">Cytotoxicity assay</head><p>The fibroblast cell-particle medium's supernatant was collected at predetermined time intervals (24 h, 48 h, and 72 h) and preserved for subsequent cytotoxicity analysis. The impact of the ZnO NPs on the fibroblast cells' cytotoxicity was determined through the Pierce lactate dehydrogenase (LDH) cytotoxicity assay kit, following the methods outlined in our prior publication <ref type="bibr">[52,</ref><ref type="bibr">53]</ref>. In brief, 50 &#956;L of each preserved supernatant was triplicated in a fresh 96-well flat-bottom plate. To each sample in the well plate, 50 &#956;L of the reaction mixture as directed by the manufacturer's instructions was added, and the 96-well plate was placed in darkness for 30 min. The positive and negative controls were established as per the manufacturer's instructions. The reaction was halted by adding 50 &#956;L of the stop solution with gentle tapping. The absorbance of the test solution in the well plate was evaluated at 490 nm and 680 nm absorbance using a CLARI-Ostar&#174; multi-mode plate reader (BMG LABTECH Inc., Cary, NC, USA). The cytotoxicity was assessed utilizing the provided equation:</p><p>where OD is the absorbance.</p><p>(1)</p><p>OD at 490 nm test sample -OD at 490 nm negative control OD at 490 nm positive -OD at 490 nm negative control &#215; 100%</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.8">Cell viability assay</head><p>The Alamar Blue (AB) colorimetric test was utilized to assess the vivacity of the 3T3 cells utilizing protocol from the manufacturer and our previous publications <ref type="bibr">[54,</ref><ref type="bibr">55]</ref>. For this test, excess media in the experimental well plate was taken out and the well plate was rinsed twice with PBS. A 5% (v/v) solution of AB reagent in the appropriate culture medium (50 &#956;L of AB reagent dissolved in 1 mL of culture medium) was added to the well plate and incubated for 4 h. The test solutions were moved to new well plates, and fluorescence was subsequently measured with a microplate reader (CLARIOstar Plus, BMG LABTECH Inc., Cary, NC, USA) with excitation at 530 nm and emission at 590 nm. The cell viability was determined with the following equation:</p><p>The viable cell morphology was observed using a fluorescence microscope on day 3. Before imaging, the cells underwent two PBS washes, were fixed with a 4% paraformaldehyde (PFA, Thermofisher Scientific) solution for 10 min, and then permeabilized with 0.2% triton (X-100) (Thermofisher Scientific) for 2 min at room temperature. The cells underwent PBS washing and were then blocked using 1% bovine serum albumin (BSA) for 30 min. The cells were subsequently stained with rhodamine-phalloidin (red) for cytoskeleton (Invitrogen, Thermo Fisher Scientific) for 20 min and DAPI (4&#8242;6, -diamidino-2-phenylindole, dihydrochloride; Invitrogen, Thermofisher Scientific), for nuclei also for 5 min both under dark conditions at room temperature. Following three rounds of PBS washing, fluorescence images were captured with an Olympus I &#215; 83 microscope (Olympus).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.9">Statistical analysis</head><p>All in vitro experiments were independently conducted in triplicate, and the data acquired underwent statistical analysis utilizing one-way analysis of variance (ANOVA) along with Tukey's post hoc test. The statistical significance of all data was determined utilizing OriginPro 2023 Version software (Origin Lab, Northampton, MA, USA) and expressed as the mean &#177; standard deviation, at n = 3) with statistical significance denoted by *p &lt; 0.05 and **p &lt; 0.01.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">Results and discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1">Synthesis of ZnO NPs</head><p>The formation of ZnO NPs is commonly indicated by a noticeable alteration in the solution's color. The introduction of zinc precursors to the plant extracts triggers the reduction of zinc ions, leading to the formation of ZnO. This reduction is accompanied by an observable shift in the color of the reaction mixture, transitioning from dark brown to light brown which ensured the synthesis of ZnO NPs. This color change is best matched in previous literature <ref type="bibr">[56]</ref>. Further, the white powdered form is obtained after treatment with a muffled furnace at 400 &#176;C for about 2 h. The phytochemicals play a major role as both reducing and capping agents in the eco-friendly synthesis of ZnO NPs. The metabolites in A. catechu extracts include tannins, terpenoids, triterpenoids, alkaloids, ascorbic acid, carbohydrates, resins, saponins, and flavonoids <ref type="bibr">[20,</ref><ref type="bibr">57]</ref>. In a study led by Adhikari et.al., Gas chromatography-mass spectrometry (GC-MS) analysis revealed that A. catechu leaf extract constituents, including, catechin, epicatechin, acacatechin, 4-hydroxybenzoic acid, mesquitol, kaempferol, baicalin, and quercetin <ref type="bibr">[58]</ref><ref type="bibr">[59]</ref><ref type="bibr">[60]</ref>. Similarly, the phytochemical analysis of A. vulgaris extract showed the occurrence of flavonoids, coumarins, volatile oils, sesquiterpenes, lactones, inulin, and a small number of alkaloids that have been characterized by (GC-MS) <ref type="bibr">[61,</ref><ref type="bibr">62]</ref>. Likewise, fatty acids (palmitic acid, stearic acid, oleic acid, and linoleic acid), tocopherol content, sterol compounds, and phenolic compounds (hydroquinone, glycerine, thymol, phytol, and ethyl glucopyranoside) were known from C. dactylon extract <ref type="bibr">[63]</ref>. In the process of bioinspired ZnO NPs synthesis, zinc ions (Zn 2+ ) derived from the precursor are found in the reaction medium. The reduction of Zn 2+ to Zn 0 is frequently facilitated by the phytochemicals in plant extracts including phenols, flavonoids, and terpenoids which donate electrons in a redox reaction to the zinc ions, initiating the nucleation and subsequent growth of ZnO NPs. Additionally, These phytochemicals not only serve as substances that reduce but also contribute to NPs stabilization by binding to their surface, preventing agglomeration, and ensuring colloidal solution stability <ref type="bibr">[27]</ref>. The method employed to synthesize ZnO NPs has benefits like eco-friendliness, biocompatibility, affordable, and efficiency while using natural resources. However, the practicality of large-scale synthesis using green sources from an industrial and commercialization perspective involves the consideration of factors like scalability; in which the variability of natural sources and specific conditions needed for green synthesis may pose challenges in maintaining consistency, reproducibility, and product quality on a larger scale <ref type="bibr">[64]</ref><ref type="bibr">[65]</ref><ref type="bibr">[66]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2">UV Spectroscopy analyses</head><p>The presence of absorption maxima at 372 nm (A. catechu), 370 nm (A. vulgaris), and 368 nm (C. dactylon) as depicted in The values obtained were close to the theoretical value of 3.37 eV. The band gap values were derived through the extension of the linear section of (&#945;hv) 2 against the hv plot until it intersected with the X-axis <ref type="bibr">[35]</ref>. The elevated band gap energy suggested ZnO NPs obtained through plant extract require higher energy to stimulate electrons from the valence to the conduction band <ref type="bibr">[69]</ref>. The observed results are consistent with several literature reports, where the absorption maximum of ZnO NPs within (340-378) nm, corresponds to a band gap energy extending from 3.1 to 3.4 eV <ref type="bibr">[2,</ref><ref type="bibr">14,</ref><ref type="bibr">68]</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3">FTIR spectroscopy analyses</head><p>The FTIR analysis revealed the existence of diverse functional groups originating from plant extracts, which act as both reducing and capping agents. The detected peaks within the (400-600) cm -1 range as shown in Fig. <ref type="figure">2</ref> are typically linked with the interaction between metal and oxygen <ref type="bibr">[35]</ref>. In particular, the existence of a peak at around 420 cm -1 indicates the stretching vibration of the Zn-O bond, confirming the existence of ZnO NPs. The peaks noted at approximately 840 and 880 cm -1 are indicative of the generation of zinc tetrahedral coordination <ref type="bibr">[71]</ref>. The appearance of a peak at 1066 cm -1 is a result of the stretching vibration of the C-O-C bond. The peaks around 1436 cm -1 imply bending bands related to C-O-H, whereas the peak around 1752 cm -1 indicates C=O stretching vibration signifying aldehyde and ketone functionality. A peak near 2340 cm -1 is associated with the nitrile group, indicating the presence of a nitrogen-containing group from plant extract. Finally, the peak close to 2980 cm -1 is a result of the stretching vibration of C-H bonds mostly of the aromatic system. All of these peaks align with those found in the literature for ZnO NPs that were synthesized using green methods <ref type="bibr">[2,</ref><ref type="bibr">35,</ref><ref type="bibr">71]</ref>. Thus, the FTIR spectrum revealed plantsynthesized ZnO NPs along with different functionalities arising due to phytochemicals found in the plant extract.</p><p>Similarly, The FTIR spectrum of C. dactylon extract exhibited prominent peaks at various wavenumbers; 3273 cm -1 (resulting from O-H bond stretching), 2980 cm -1 (C-H stretching), 2338 cm -1 (N-H stretching), 1592 cm -1 (associated with C=C bond vibration), and 1394 cm -1 along with 1341 cm -1 (related to C-H bending) <ref type="bibr">[72,</ref><ref type="bibr">73]</ref>. Likewise, The FTIR spectrum of A. vulgaris extract exhibited prominent peaks at various wavenumbers: 3424 cm -1 (broad peak revealing the presence of a strong H-bonded hydroxyl group associated with alcohol, phenols, or carboxylic acid), 2971 cm -1 and 2900 cm -1 (resulting from C-H bond stretching), 2334 cm -1 (related with stretching mode of the CO group) and 1648 cm -1 (associated with the CO group in amides) <ref type="bibr">[74]</ref>. Finally, looking at the FTIR spectrum of A. catechu extract, peaks around 3273 cm -1 (corresponds to -OH stretching), 2980 and 2900 cm -1 (suggests the presence of C-H bonds), 2301 cm -1 (associated with -CN group), 1564 and 1398 cm -1 (suggests the carbonyl groups in ketone and esters) <ref type="bibr">[75]</ref>. Thus, the result indicates the existence of flavonoids, phenols, amines, amino acids, etc. in plant extracts that play a role in reducing and capping ZnO NPs during the synthesis process. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4">X-ray diffraction (XRD) analyses</head><p>XRD analysis was conducted to examine the crystalline nature and structural characteristics of plant-mediated synthesized ZnO NPs. The XRD diffraction pattern revealed distinct peaks detected at 2&#952; angles of <ref type="bibr">31.64, 34.29, 36.12, 47.42, 56.49, 62.76, 66.32, 67.87, and 68.96</ref> for ZnO NPs synthesized from C. dactylon. Similarly, 2&#952; values of <ref type="bibr">31.60, 34.24, 36.07, 47.39, 56.43, 62.72, 66.26, 67.80, and 68.94</ref> for ZnO NPs synthesized from A. vulgaris and finally, 2&#952; values of <ref type="bibr">31.60, 34.25, 36.07, 47.37, 56.44, 62.71, 66.36, 67.82, and 68.97</ref> for ZnO NPs synthesized from A. catechu associated to their miller indices of (100), (002), ( <ref type="formula">101</ref>), ( <ref type="formula">102</ref>), ( <ref type="formula">110</ref>), ( <ref type="formula">103</ref>), ( <ref type="formula">200</ref>), ( <ref type="formula">112</ref>) and ( <ref type="formula">201</ref>) respectively as shown in Figure <ref type="figure">S5</ref>, S6, and S7, which is similar with those reported in previous literature <ref type="bibr">[22,</ref><ref type="bibr">26,</ref><ref type="bibr">71]</ref>.</p><p>The observed pattern corresponds to a hexagonal wurtzite structure of ZnO NPs, featuring lattice parameters a = 3.26 (&#197;) and c = 5.23 (&#197;) as evidenced by its conformity with JCPDS card no. 36-1451 as depicted in Fig. <ref type="figure">3</ref>, a consistency observed in multiple studies <ref type="bibr">[34,</ref><ref type="bibr">35,</ref><ref type="bibr">67]</ref>. The findings indicated all the identifiable peaks were specific to ZnO NPs and intense peaks signify no impurities detected in the preparation of ZnO NPs. The mean crystallite size was achieved by applying the Debye-Scherrer formula, yielding measurements of 18.97 nm, 16.98 nm, and 15.07 nm for ZnO NPs synthesized from C. dactylon, A. vulgaris, and A. catechu respectively as shown in Table <ref type="table">S1</ref>, S2, and S3.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.5">Scanning Electron Microscopy (SEM) analyses</head><p>SEM provides important information regarding surface morphology, aggregation, size, and distribution of nanoparticles <ref type="bibr">[76]</ref>. Higher magnification shows a clearer image where NPs are seen to be identical in shape and dimension. SEM disclosed the uniform spherical structure of ZnO NPs, displaying slight agglomeration likely attributed to the Vander Waals clustering of smaller entities as shown in Fig. <ref type="figure">4</ref> below. Several works of the literature suggest that agglomeration is due to phytochemical moieties present on the particle surface, high surface area, polarity, and electrostatic attraction of biologically synthesized NPs, or it could be attributed to experimental parameters during the synthesis process such as variation in temperature and pH of the medium <ref type="bibr">[71,</ref><ref type="bibr">77,</ref><ref type="bibr">78]</ref>.</p><p>Various studies have documented the spherical shape of ZnO NPs at lower precursor concentrations and spherical mixed with hexagonal and cubical at higher concentrations <ref type="bibr">[2,</ref><ref type="bibr">79]</ref>. Similarly, using SEM images and the assistance of Image J software, the average size of ZnO NPs was calculated by assessing the mean length of the ten smallest particles observed in the image. The obtained mean diameter of ZnO NPs synthesized from C. dactylon, A. vulgaris, and A. catechu was 17.83 nm, 17.82 nm, and 18.5 nm, respectively. These values align well with the average size determined through XRD studies. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.6">Energy dispersive X-ray spectroscopy (EDX) analyses</head><p>The elemental components, relative abundance, and presence of impurities in nanoparticles are demonstrated through EDX <ref type="bibr">[76]</ref>. EDX revealed that the synthesized structure possesses the targeted elemental composition of zinc and oxygen along with traces of sodium and potassium. The existence of these additional elements can be ascribed to the occurrence of various metabolites present in the plant extract as illustrated in Figs. 5, S8, and S9. The detection of Zn and O peaks confirmed the existence of zinc in oxide form. In Figures, Zn and O signals were detected between (0-2) KeV, and two Zn signals were obtained between (8-10) KeV which is similar to those found in several literatures <ref type="bibr">[2,</ref><ref type="bibr">27,</ref><ref type="bibr">80]</ref>.</p><p>The weight % of Zn and O from C. dactylon was 74.44% and 20.08%, A. vulgaris was 69.76% and 21.75%, and A. catechu was 74.43% and 18.30% showing greater purity for ZnO NPs synthesized using C. dactylon and A. catechu as shown in Table <ref type="table">S4</ref>-6 respectively. The wt. % peaks closely resemble those documented earlier in the biosynthesis of ZnO NPs <ref type="bibr">[26,</ref><ref type="bibr">78,</ref><ref type="bibr">81]</ref>. The theoretical weight % of Zn in ZnO is 80.34% and the reduction of wt. % of Zn in the above compound is ascribed to the existence of a certain amount of sodium and potassium obtained from plant extract. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.7">Antibacterial susceptibility assay</head><p>The synthesized ZnO NPs were evaluated for their antibacterial efficacy against both gram-positive (Staphylococcus aureus, Kocuria rhizophila) and gram-negative bacteria (Klebsiella pneumonia, Shigella sonnei) by disc diffusion method <ref type="bibr">[48]</ref>. Figures 6, S10 The NPs, plant extract, and blank all showed antibacterial activity against Klebsiella pneumonia. In comparison, ZnO NPs obtained from A. vulgaris and A. catechu (ZOI of 14 mm) showed better results than that of ZnO NPs from presence of potent bioactive components. Similarly, ZnO NPs obtained from A. vulgaris extract showed overall good potency against all bacterial strains.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.8">Cytotoxicity and cell viability analyses</head><p>The cell viability and cytotoxicity plots shown in Fig. <ref type="figure">9</ref> demonstrate that all groups of ZnO NPs concentrations were viable except the samples with the higher dose of the ZnO NPs i.e., AC-50, AV-50, and CD-50. The viability of this cell line was found to be dependent on both the dose and incubation time with the ZnO NPs. Extending the incubation time from 24 to 72 h resulted in a positive effect on cell growth particularly for the lower doses. Numerous prior studies have reported the dose-dependent cytotoxic effect of ZnO NPs <ref type="bibr">[86]</ref><ref type="bibr">[87]</ref><ref type="bibr">[88]</ref><ref type="bibr">[89]</ref>. In a study led by Maede Hasannasab, lower concentrations of ZnO-NPs promoted the adhesion and multiplication of fibroblast cells whereas higher doses reversed the trend when higher doses were applied <ref type="bibr">[90]</ref>. Morphological features of the ZnO-NPs had a significant influence on cancer cells. The shape, size, and concentrations of ZnO NPs are crucial factors that determine their effectiveness in combating cancer <ref type="bibr">[91,</ref><ref type="bibr">92]</ref>. The involvement of reactive oxygen species (ROS) in cell replication, differentiation, and transcription could be used to explain the increased proliferation of fibroblasts observed at lower concentrations of ZnO NPs <ref type="bibr">[93,</ref><ref type="bibr">94]</ref>. The fluorescence images in Fig. <ref type="figure">10</ref> showed the accelerated growth in cells as doses of the ZnO NPs increase but it's not the same with the higher dose. This means that the cells can only contain a certain level of concentration of the ZnO NPs to be viable. It was also evident from the plots of biocompatibility tests that the viability of ZnO NPs from the C. dactylon group was comparatively higher than the others. The biocompatibility of the green synthesized ZnO NPs makes it more susceptible for biological and therapeutic purposes like antiviral, anti-inflammatory, antioxidant, and anti-diabetic activities due to its positive effect on cell proliferation <ref type="bibr">[9]</ref>. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4">Conclusions</head><p>ZnO NPs can be synthesized utilizing the plant-mediated technique that is environmentally friendly and a good alternative to traditional techniques. The synthesized ZnO NPs were confirmed with UV-visible spectroscopy. The nature, size, and structure of ZnO NPs were revealed through XRD. FTIR Spectroscopy showed evidence of the incorporation of phytochemicals during ZnO NPs synthesis. SEM analysis demonstrated that ZnO NPs exhibited a spherical shape. Synthesized ZnO NPs exhibited antimicrobial effect and biocompatibility with NIH-3T3 mouse fibroblast cells. Among the ZnO nanoparticles (NPs) prepared from the three distinct extracts, those derived from A. catechu exhibited the smallest crystallite size. Furthermore, the percentage composition of Zn and O in the A. catechu NPs was superior to that of the other two extracts. In contrast, the SEM image of ZnO NPs obtained from A. vulgaris displayed a comparably spherical shape with slight agglomeration compared to the other two extracts. Moreover, both ZnO NPs synthesized from A. catechu and A. vulgaris demonstrated good antibacterial activity. Cell viability and toxicity analysis revealed that ZnO NPs prepared from C. dactylon exhibited relatively higher viability compared to the NPs obtained from the other extracts. Hence, the results of this study suggest that ZnO NPs synthesized ZnO NPs using C. dactylon, A. vulgaris, and A. catechu plant extract hold promising potential for biomedical applications.</p><p>Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ref type="url">http:// creat</ref> iveco mmons. org/ licen ses/ by/4. 0/. </p></div></body>
		</text>
</TEI>
